The Role of Alpha-2 Agonists for Attention Deficit Hyperactivity Disorder in Children: A Review.
Elisa E NeuchatBrooke E BockludKali KingsleyWilliam T BarhamPatrick M LutherShahab AhmadzadehSahar ShekoohiElyse M CornettAlan David KayePublished in: Neurology international (2023)
Despite these concerns, Alpha-2 agonists remain a valuable treatment option for ADHD in children, especially those unable to tolerate stimulant medications or who have coexisting conditions such as tic disorders. Future research should continue to explore the safety and efficacy of Alpha-2 agonists in the long term. In conclusion, Alpha-2 agonists show promise as a treatment for ADHD in children; however, the safety and efficacy of these drugs in the long term are not yet completely understood. Additional studies are required to investigate the optimal dose and treatment duration for these medications in their use as a treatment for this debilitating disease.